Cart
sales@molnova.com
Raloxifene
CAS No. 84449-90-1
Raloxifene( Pharoxifene | Raloxifenum | Keoxifene | LY-139481 )
Catalog No. M24833 CAS No. 84449-90-1
Raloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 56 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 405 | In Stock |
|
| 200MG | 585 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRaloxifene
-
NoteResearch use only, not for human use.
-
Brief DescriptionRaloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
DescriptionRaloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
In Vitro——
-
In VivoRaloxifene (4?mg/kg; intragastrically; daily for 13 weeks) significantly prevents bone loss in ovariectomized (OVX) rats. Animal Model:Female, 12-week-old, Wistar rats (OVX rats) Dosage:4?mg/kg Administration:Intragastrically; daily for 13 weeks Result:Significantly increased the levels of E2 in OVX rats and significantly decreased the levels of BGP.
-
SynonymsPharoxifene | Raloxifenum | Keoxifene | LY-139481
-
PathwayOthers
-
TargetOther Targets
-
RecptorSERM
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84449-90-1
-
Formula Weight473.58
-
Molecular FormulaC28H27NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:90 mg/mL (190.04 mM; Need ultrasonic)；Ethanol:9 mg/mL (19.00 mM; Need ultrasonic)
-
SMILESOc(cc1)ccc1-c1c(C(c(cc2)ccc2OCCN2CCCCC2)=O)c(ccc(O)c2)c2s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khovidhunkit W, et al. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999;130(5):431-439.
molnova catalog
related products
-
Furnidipine
Furnidipine significantly reduced AoD and AF and had antiarrhythmic and cardioprotective effects at low doses in a rat model.
-
Glutaminase-IN-3
Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.
-
R-E-D-V
REDV is the minimal active sequence within the CS5 site of the alternatively spliced type III connecting segment (IIICS) region of fibronectin. REDV can mediate adhesion to the IIICS region of plasma fibronectin by binding the integrin alpha 4 beta 1(α4β1). REDV can be used for the research of cell adhesion.
